Clinical Trials Sponsored by Nico Corporation

Total 7276 results

Viz.ai, Inc.
Nico Corporation

Enrolling by invitation

AI ENRICH - AI Detection of ICH

Intracerebral Hemorrhage

United States
Nico Corporation
Emory University

Completed

ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) (ENRICH)

Cerebral Hemorrhage | Intracerebral Hemorrhage | Intracerebral Haemorrhage

United States
University of Maryland, Baltimore
Nico Corporation

Recruiting

Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone (ENRICHPLUS)

Intracerebral Haemorrhage, Intraventricular

United States
Baptist Health South Florida
Nico Corporation; Miami Cancer Institute

Not yet recruiting

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Glioblastoma | Glioblastoma Multiforme | Gliosarcoma

United States
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Kimberly-Clark Corporation
University Medical Center Groningen; NIZO Food Research

Completed

Ex Vivo High-Throughput Assay for Vaginal Community Post-menopausal Women (FLORA)

Postmenopausal Syndrome

Netherlands
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Germany

Viral Conjunctivitis

Germany
NicOx

Completed

A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure (HCT3012-X-111)

Hypertension | Osteoarthritis

United States
NicOx

Completed

A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects

Liver Disease

United States
NicOx

Completed

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip

Osteoarthritis | Osteoarthritis, Hip

United States, Canada
NicOx

Completed

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function (HCT3012-X-106)

Renal Failure

United States
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Spain

Viral Conjunctivitis

Spain
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in UK

Viral Conjunctivitis

United Kingdom
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in France

Viral Conjunctivitis

France
NicOx

Completed

Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

Pharmacokinetics
NicOx

Completed

Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide

Renal Hemodynamics
NicOx

Completed

Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

Osteoarthritis
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Italy

Viral Conjunctivitis

Italy
NicOx

Completed

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

Osteoarthritis

United States
NicOx

Completed

To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension (HCT3012-X-112)

Hypertension | Osteoarthritis

United States
Quesada, Rocío Vico

Not yet recruiting

Post- Rotatory Nystagmus Test: Normative Data for Spanish Adolescents and Adults

Vestibular Function Tests | Nystagmus Vestibular
Nicox Ophthalmics, Inc.

Completed

Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis

Blepharitis

United States
Nicox Ophthalmics, Inc.

Completed

Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Mont Blanc)

Ocular Hypertension | Open Angle Glaucoma

United States
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Nicox Ophthalmics, Inc.

Recruiting

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution (Whistler)

Open Angle Glaucoma

United States
Nicox Ophthalmics, Inc.

Recruiting

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)

Ocular Hypertension | Open Angle Glaucoma

United States, China
Niso Biomed S.R.L.

Unknown

Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy

Helicobacter Infections

United Kingdom
Kimberly-Clark Corporation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); NIZO Food...

Completed

Rudolph: Nasal Microbiota With Red and Sore Nose

Dermatitis

Netherlands
Clinica las Condes, Chile
Solta Medical; Corporacion de ayuda al niño quemado (COANIQUEM)

Unknown

Fractional Photothermolysis for the Treatment of Burn Scars

Scar

Chile
Nicox Ophthalmics, Inc.

Completed

Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis (Mississippi)

Blepharitis

United States
Nicox Ophthalmics, Inc.

Completed

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Glaucoma, Open-Angle | Hypertension, Ocular

United States
NIZO Food Research

Completed

Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli (CORAL)

Gastroenteritis | Diarrhea | Bacterial Infections | Escherichia Coli Infections

Netherlands
Shanghai Antengene Corporation Limited

Terminated

A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (HATCH)

Myelodysplastic Syndrome

China
Shanghai Antengene Corporation Limited

Terminated

A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)

Advanced Solid Tumors

China

Clinical Trials Sponsored by Nico Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations